Status:
COMPLETED
Effectiveness of Screening and Brief Interventions for Alcohol and Tobacco During Breast Cancer Treatment (ONKODETOX)
Lead Sponsor:
Institut Bergonié
Collaborating Sponsors:
Ligue contre le cancer, France
Conditions:
Breast Cancer
Psychology, Social
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Despite scientific, clinical and political incentives, alcohol and/or tobacco screening and brief intervention (SBI) services are poorly implemented in oncology settings. Motivational brief interventi...
Detailed Description
Context : It is now well documented that alcohol and tobacco reduce the effectiveness of a treatment, increase the side effects, favor the recurrence and/or secondary cancers and affects the quality ...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- women with primary breast cancer, without ongoing support for substance use.
- An AUDIT-C score \>1 or more than one cigarette smoked per day.
- Individuals able to consent to benefit of intervention focused on substance use. (Karnofsky Index \>70).
- Exclusion Criteria :
- Patients who currently use substances for which a second-line care is already committed.
- Patients with a Karnofsky index \<70.
Exclusion
Key Trial Info
Start Date :
March 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT03371732
Start Date
March 1 2016
End Date
April 1 2019
Last Update
December 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Bergonie
Bordeaux, France, 33076